Europe Orthopedic Devices Market to Reach USD 21.67 Billion by 2035, Growing from USD 15.15 Billion in 2025 - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - Large joint replacement volumes, waiting list reduction, an ageing population and robotics and digital surgery are supporting steady growth in orthopedic devices across Europe.

https://www.strategicrevenueinsights.com/industry/europe-orthopedic-devices-market

The Europe Orthopedic Devices market was valued at USD 15.15 billion in 2025 and is projected to reach USD 21.67 billion by 2035, growing at a CAGR of 3.6%, according to Strategic Revenue Insights Inc. The report was prepared by lead analyst Anirudh Singh. The research methodology combines primary interviews with relevant industry stakeholders, including orthopedic device manufacturers, hospitals, ambulatory surgical centers and public health procurement bodies, with secondary data across the regions covered by the report.

KEY TAKEAWAYS

Market value is projected to rise from USD 15.15 billion in 2025 to USD 21.67 billion by 2035, at a CAGR of 3.6%.

Joint Reconstruction is the largest product segment with a 38.00% share, while Orthobiologics is the fastest-growing at a 4.4% CAGR.

Knee is the largest application at 30.00% while Shoulder grows fastest at 4.2%, and Hospitals and Clinics hold 78.00% while Ambulatory Surgical Centers grow fastest at 5.3%.

Germany is the largest country market with a 24.00% share, valued at USD 3.64 billion in 2025, while Poland is the fastest-growing country at a 4.6% CAGR.

Named market participants include Zimmer Biomet, Stryker, and DePuy Synthes (Johnson & Johnson).

Full report access: https://www.strategicrevenueinsights.com/industry/europe-orthopedic-devices-market

GROWTH DRIVERS AND TRENDS

Large joint replacement volumes are the largest growth driver, adding an estimated 1.2 percentage points to the CAGR, followed by waiting list reduction at 1.0 point, the ageing population at 0.8 points, and robotics and digital surgery at 0.7 points, for a combined 3.7 points. The source projects the market at USD 18.08 billion in 2030.

Key trends identified in the report include robotics and digital planning spreading beyond leading hospitals, ambulatory care expanding from a small base, product rationalisation under the EU Medical Device Regulation, and bundled offers combining implants, instruments and services. Opportunities include independent-sector joint replacement capacity, robotics and digital planning, and sports medicine and orthobiologics. 2035 scenarios range from USD 18.50 billion to USD 24.50 billion.

MARKET SEGMENTATION

By product, the market is segmented into Joint Reconstruction (38.00%), Spinal Devices (18.00%), Trauma Fixation (17.00%), Arthroscopic and Sports Medicine (11.00%), Orthopedic Braces and Supports (10.00%), and Orthobiologics (6.00%). Joint Reconstruction is the largest segment with a 3.9% CAGR, and Orthobiologics is the fastest-growing at 4.4%, followed by Arthroscopic and Sports Medicine at 4.1%.

By application, the market covers Knee (30.00%), Hip (24.00%), Spine (20.00%), Foot and Ankle (17.00%), and Shoulder (9.00%). Knee is the largest segment with a 3.8% CAGR, and Shoulder is the fastest-growing at 4.2%.

By end user, the market includes Hospitals and Clinics (78.00%), Ambulatory Surgical Centers (12.00%), and Others (10.00%). Hospitals and Clinics is the largest segment with a 3.4% CAGR, and Ambulatory Surgical Centers is the fastest-growing at 5.3%.

REGIONAL OUTLOOK

The report covers Germany, the United Kingdom, France, Italy, Spain, the Netherlands, Poland, Belgium, and the Rest of Europe. Germany is the largest country market with a 24.00% share, valued at USD 3.64 billion in 2025 and projected to reach USD 5.10 billion by 2035 at a 3.4% CAGR. The United Kingdom holds 17.00% (USD 2.58 billion, rising to USD 3.72 billion) with a 3.7% CAGR, France 14.00% (USD 2.12 billion, rising to USD 2.97 billion) with 3.4%, Italy 11.00% (USD 1.67 billion) with 3.3%, and Spain 8.00% (USD 1.21 billion) with 3.8%. Poland (5.00%, USD 757.50 million rising to USD 1.19 billion) is the fastest-growing country at a 4.6% CAGR, the Netherlands holds 4.00% with 3.5%, Belgium 3.00% with 3.4%, and the Rest of Europe 14.00% (USD 2.12 billion) with 3.9%.

COMPETITIVE LANDSCAPE

The report profiles Zimmer Biomet (US, 9.5% share), which supplies knee and hip implants, robotic guidance and sports medicine products to European hospitals; Stryker (US, 9.0%), which sells robotic-enabled knee and hip systems, trauma fixation and spinal implants; DePuy Synthes (Johnson & Johnson) (US, 8.0%), which offers knee and hip systems, robotics, trauma plates and spinal implants; Smith & Nephew (UK, 7.5%), which sells knee and hip implants, a surgical robot and arthroscopy equipment; B. Braun (Aesculap) (Germany, 7.0%), which supplies knee and hip implants, spinal systems and surgical instruments; and Medtronic (Ireland, 4.5%), which provides spinal implants, navigation and biologics. Waldemar Link (3.0%), LimaCorporate (Enovis) (2.5%), Corin Group (2.0%) and Mathys (1.8%) are also covered.

MARKET RESTRAINTS

The EU Medical Device Regulation reduces the CAGR by an estimated 0.6 percentage points, and tender pricing in public systems subtracts a further 0.4 points. The report also cites MDR certification costs and product withdrawals, public tender price pressure, and hospital budget limits.

RELATED REPORTS

https://www.strategicrevenueinsights.com/industry/north-america-disposable-infusion-sets-market

https://www.strategicrevenueinsights.com/industry/asia-pacific-orthopedic-devices-market

https://www.strategicrevenueinsights.com/industry/radioligand-therapy-market

https://www.strategicrevenueinsights.com/industry/fill-finish-services-market

https://www.strategicrevenueinsights.com/industry/hospital-at-home-market

https://www.strategicrevenueinsights.com/industry/ai-medical-scribe-market

https://www.strategicrevenueinsights.com/industry/north-america-orthopedic-devices-market

https://www.strategicrevenueinsights.com/industry/in-vivo-car-t-therapy-market

https://www.strategicrevenueinsights.com/industry/ai-drug-repurposing-market

https://www.strategicrevenueinsights.com/industry/antimicrobial-medical-textiles-market

FREQUENTLY ASKED QUESTIONS

What is the Europe Orthopedic Devices market size in 2025?

The market was valued at USD 15.15 billion in 2025.

What is the Europe Orthopedic Devices market forecast for 2035?

The market is projected to reach USD 21.67 billion by 2035, growing at a CAGR of 3.6%.

Which segment is largest in the Europe Orthopedic Devices market?

Joint Reconstruction is the largest product segment with a 38.00% share, and Knee is the largest application with a 30.00% share.

Which region leads the Europe Orthopedic Devices market?

Germany is the largest country market with a 24.00% share, valued at USD 3.64 billion in 2025 and projected to reach USD 5.10 billion by 2035 at a 3.4% CAGR. The United Kingdom holds 17.00% (USD 2.58 billion, rising to USD 3.72 billion) with a 3.7% CAGR, France 14.00% (USD 2.12 billion, rising to USD 2.97 billion) with 3.4%, Italy 11.00% (USD 1.67 billion) with 3.3%, and Spain 8.00% (USD 1.21 billion) with 3.8%. Poland (5.00%, USD 757.50 million rising to USD 1.19 billion) is the fastest-growing country at a 4.6% CAGR, the Netherlands holds 4.00% with 3.5%, Belgium 3.00% with 3.4%, and the Rest of Europe 14.00% (USD 2.12 billion) with 3.9%.

MEDIA CONTACT INFORMATION
Company Name: Strategic Revenue Insights Inc.
Contact Person: Rohit Bhisey
Email: sales@strategicrevenueinsights.com
Phone: +44 7877403352
Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL
City: London
State: London
Country: United Kingdom

Strategic Revenue Insights Inc.
Rohit Bhisey
Suite 10, Capital House, 61 Amhurst Road, E8 1LL
London, United Kingdom
sales@strategicrevenueinsights.com
+44 7877403352

Strategic Revenue Insights Inc., a distinguished subsidiary of SRI Consulting Group Ltd, stands as a premier provider of data-driven market intelligence, empowering organizations globally to navigate complex business landscapes with confidence and precision. Headquartered in London, United Kingdom, our firm specializes in delivering comprehensive syndicated research reports, bespoke consulting solutions, and actionable strategic insights that enable clients to make informed, forward-thinking decisions in an increasingly competitive marketplace.

Our dedicated team of accomplished analysts, strategically positioned in London with an extensive global network, maintains continuous vigilance over evolving market dynamics, identifying emerging trends and uncovering high-potential growth opportunities that drive sustained client success. As an integral component of SRI Consulting Group Ltd, we uphold unwavering commitments to analytical accuracy, clarity of presentation, and practical applicability, assisting organizations in navigating competitive terrain, optimizing strategic initiatives, and accelerating revenue trajectories.

Through the integration of rigorous research methodologies with profound industry expertise, Strategic Revenue Insights Inc. delivers comprehensive market perspectives that generate measurable outcomes and establish enduring competitive advantages for our clients across diverse sectors and geographies.

Corporate Websites:
www.strategicrevenueinsights.com
www.strategicpackaginginsights.com
www.sriconsultinggroupltd.com
https://strategicrevenueinsights.blog/
https://medium.com/@strategic-revenue-insights.inc
https://www.strategicrevenueinsights.com/press-releases

This release was published on openPR.